Development of an open metadata schema for Prospective Clinical Research (openpcr)
|
|
- Brandon Horn
- 8 years ago
- Views:
Transcription
1 Supplementary Web Material Development of an open metadata schema for Prospective Clinical Research (openpcr) in China A. Methods We used Singapore Framework for Dublin Core Application Profiles (DCAP), a generic construct for designing metadata records, [1] to develop openpcr. The framework holds the design and documentation components of specific metadata applications which can be grouped into four processes for metadata schema development: defining functional requirements, developing a domain model, defining metadata terms and designing a metadata record, and finally developing implementation syntax. We followed the four steps in modeling openpcr. A.1 Step 1: Define the Core Functional Requirements and Deduce the Core Metadata Items Defining specific goals of openpcr was an essential first step [1]. We used business process modeling method to define the top level objective. The general business process cycle of conducting a CR includes defining the problem and reviewing the relevant literature, preparing and approving a protocol, conducting research and collecting data, analyzing data and completing the final report, and producing new hypothesis [2, 3]. Designing openpcr is in the process of preparing and approving a protocol. Before conducting CR, researchers will develop a protocol, register to clinical registry and design case report form (CRF). The Declaration of Helsinki states Every clinical trial must be registered in a publicly accessible
2 database before recruitment of the first subject [4]. CRF, defined as a printed, optical, or electronic document designed to record all of the protocol required information to be reported to the sponsor on each trial subject, is the major clinical data collection tool [5]. The protocol is one of the most important documents in CR. Its general information is useful for registration, and trial design information is of the most importance in developing data collection tools [5, 6]. We defined the registration information, trial design information and CRF information as the basic information in developing openpcr, so the top level objective of openpcr can be specifically described as developing a metadata schema for research registration, trial design and CRF (Figure 1). Figure 1: Clinical research process and openpcr objective We then used both business process modeling method and literary warrant method to create the core functional requirements. We systematically reviewed hundreds of sources in standards, regulation, best practice guidelines, and studies on trial registration and development of CR data schema. Based on the top level objective, we divided the core functional requirements into three parts: requirements for research registration, requirements for trial design, and requirements for CRF. We further examined the specific business process
3 of registration, trial design and CRF, created specific requirements from selected sources, and deduced specific metadata items. The selected sources included two standard guidelines, five clinical trial registry documents, and two standards for clinical data submission and one standard for clinical data collection issued by the Clinical Data Interchange Standards Consortium (CDISC). Two standard guidelines are ICH GCP (International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use - Good Clinical Practice) [5] and DCTQCS (Drug Clinical Trial and the Quality Control Standard of China) [7]. ICH GCP is an international ethical and scientific quality standard controlling the whole process cycle of CR. Its main purpose is to protect not only research subject but also the quality and credibility of data. DCTQCS of China has come into force since Based on the Pharmaceutical Administration Law of China and referenced by ICH GCP, it basically conforms to international standards and national circumstances. The trial design parts of ICH GCP and DCTQCS are important sources for trial design requirements. Five clinical trial registry documents are Ottawa Statement on Trial Registration [8], the WHO Trial Registration Data Set [9], and data sets in ClinicalTrial.gov (USA) [10], Chinese Clinical Trial Registry (China) [11] and ISRCTN Register (Britain) [12]. In creating the core functional requirements of registration, we reviewed Ottawa Statement, a guide to implement global trial registration. WHO Trial Registration Data Set (TRDS) was also included which provides the minimum amount of trial information that must appear in a register in order for a given trial to be considered fully registered. We also elicited those mandatory elements from ClinicalTrial.gov [13], ChiCTR and ISRCTN [11, 14] that are not embraced by TRDS,
4 because they were often registered databases for Chinese researchers [15]. Two standards for clinical data submission and one standard for clinical data collection issued by CDISC are Study Data Tabulation Model (SDTM) [16], SDTM Implementation Guide (SDTMIG) [17], and Clinical Data Acquisition Standards Harmonization (CDASH) [18]. STDM, STDMIG and CDASH are standards focusing on creating trial design and data collection requirements. STDM defines standard datasets and variables collected and submitted to a regulatory authority, and STDMIG provides specific details and examples for preparing standard datasets based on STDM. The Trial Design Model in the STDM represents standard datasets describing the plan of a clinical trial and helping to determine what data to be collected. CDASH describes basic standard data fields for the collection of clinical trial data. STDM and CDASH are closely related and harmonized, and both of them are intended for the collection of clinical data. If identical data are met between the two standards, the CDASH data collection fields would adopt the SDTM variable names. Based on the selected sources, we created the framework of core functional requirements, developed the requirements specification and deduced core metadata items. A.2 Step 2: Develop Archetype Models The next step was to develop archetype models based on the core metadata items. An archetype model is a kind of domain model containing openpcr metadata structure and relationships, and is the basic blueprint for the construction of the archetype records. During this process, metadata items were standardized, reorganized and structured to form archetype models. Structures of archetype models were visualized in a mind map. Firstly, metadata items of the same semantic meaning and content were combined
5 according to the core functional requirements result. Then, we standardized the Chinese term of each metadata item since most of them are from sources in other countries and organizations. As to metadata items deduced from the requirements of registration, we used the Chinese names of data fields in Chinese ChiCTR registry as the authority names which correspond to item names in TRDS, ClinicalTrial.gov and ISRCTN. Metadata items from requirements of trial design and CRF are clinical related data. We used National Health Data Dictionary (NHDD) [19] and EHR Architecture and Data Standard of China (Chinese EHR Standard) [20] as the standard name source. If there was a corresponding Chinese authority name, we adopted the name. If there was no corresponding Chinese name, we gave the name to the metadata item deliberately and consistently. Then we grouped archetypes into four categories according to Data Structure in Chinese EHR Standard. Data Structure in Chinese EHR Standard includes four hierarchical levels: document, section, data group, and data element. A document is the top level container, and can be organized into sections or data groups. Sections provide logical categories, and can be divided into a number of data groups. A section can be defined by its contained data groups. A data group is a collection of data elements or smaller data groups for holding related items of information. The data element is an indivisible data unit represented by data attributes such as identifier, definition, representation, and value domain. Data Structure in Chinese EHR Standard is analogous to EHR Information Model in openehr. We used Data Structure in Chinese EHR Standard as the information model of openpcr for future consideration of EHR and CR integration. Based on the four hierarchical levels of Data Structure in Chinese EHR Standard, we developed four classes of archetypes: document, section, data group, and data
6 element. Document archetypes were the top level archetypes that include public document, internal document, and clinical document which correspond to the top level requirements of registration, trial design, and CRF. Both data group archetypes and data element archetypes could be reused and combined into other archetypes. In public document archetype, data elements for registration are general information including title, identification, summary, and etc., and most of them are in compliance with elements in Dublin Core (DC) Metadata Element Set [21]. Since DC Metadata Element Set is a widely accepted metadata standard, which provides a means for categorizing and describing resources, and makes public registration information more easily searchable and deliverable on the web, we used it to structure and represent data in public document. Internal document archetype includes trial design information. Internal document can not only help to model the structured protocol [6], but also provide value domains for clinical metadata. The trial design information is mainly from ICH GCP, DCTQCS and SDTM. ICH GCP and DCTQCS provide required description information of trial design, while SDTM provides five datasets: Trial Arms, Trial Elements, Trial Visits, Trial Inclusion/Exclusion, Trial Summary, and study identification information [14]. The Trial Summary dataset contains information about the planned trial characteristics, mainly represented in public document and we did not include Trial Summary dataset in internal document. Therefore, internal document contained data group about design description, study identification, arms, elements, visits, and inclusion/exclusion. Unlike study-level metadata containers as public document and internal document, clinical document includes subject-level metadata and is broken up into a header section and a body
7 section. The header section is composed of subject identifier, arm, specific study visit, and etc. The body section includes clinical data for CRF corresponding to each study visit. Most of CDASH Domain Tables have corresponding domains in STDM. We made each CDASH Domain Table the top level data group in the body section, and converted variables of Category and Subcategory in corresponding domain in SDTM into smaller hierarchical data groups. When the core data elements under the top level data group can be reused by the smaller data groups, we created a generic data group containing the core data elements. Smaller data groups can reference the generic data group as a slot. If a CDASH domain table has a corresponding data group in Chinese EHR Standard, we analyzed the data group and determined if the structure of the data group could be used to categorize the CDASH domain table into lower data groups. For example, the domain table of physical examination in CDASH has a corresponding data group of Physical Examination in Chinese EHR Standard which is divided into ten categories: General Appearance, Skin, Lymph Node, Head, Neck, Chest, Abdomen, Genital Anal Rectum, Spine and Limbs, and Function (Disability). Then in the body section of clinical document, data group: Physical Examination includes smaller data groups of General Appearance, Skin, Lymph Node, Head, Neck, Chest, Abdomen, Genital Anal Rectum, Spine and Limbs, and Function (Disability). All the smaller data groups have three core data elements: Body System Examined, Examination Result, and Abnormal Findings. We formed a generic data group of physical examination containing three data elements: Body System Examined, Examination Result, and Abnormal Findings, which can be reused by data groups under physical examination as a slot.
8 A.3 Step 3: Define Metadata Terms and Develop Archetype Records As a kind of domain model, the archetype model represents concepts and relationships among them, and is always described using notations for modeling. An archetype record is based on archetype models, and is a technical specification holding metadata and metadata attributes within archetypes. Archetypes are grouped into four categories according to Data Structure in Chinese EHR Standard: document, section, data group, and data element. Document, section and data group are container metadata. The data element is the smallest named metadata that can be assigned with a value. All the metadata can be described by metadata attributes. Basic attributes facilitate the common understanding of the meaning and representation of the metadata [22] and constrain specifying technical details such as the obligation or occurrence of elements or restrictions on allowable values. In order to keep the definition consistency, avoid definition duplication, and increase metadata interoperability across China, we defined the openpcr metadata in accordance with ISO/IEC :2003(E) Information technology - Metadata registries (MDR) - Part 3: Registry metamodel and basic attributes (ISO ) [22] and metadata attributes in NHDD and Chinese EHR Standard. ISO/IEC specifies 45 basic metadata attributes grouped to seven categorizes including: Common attributes, Attributes specific to Data Element Concepts, Attributes specific to Data Elements, Attributes specific to Conceptual Domains, Attributes specific to Value domains, Attributes specific to Permissible Values, Attributes specific to Value Meanings. Common attributes are further categorized as: Identifying, Definitional, Administrative, and Relational. Metadata attributes in NHDD and Chinese EHR Standard are developed based on ISO/IEC
9 NHDD specifies five attribute categories including: Identifying and definition, Collection and usage guides, Source and reference, Relation, and Administration with 24 metadata attributes. Chinese EHR Standard contains six classes of attributes: Identification, Definition, Relation, Representation, Administration, and Extension with 17 mandatory metadata attributes. Extension class includes attributes for usage guides. In openpcr, we grouped metadata attributes into six categories according to NHDD and Chinese EHR Standard: Identification, Definition, Relation, Representation, Administration, and Usage guides. Container metadata such as document, section and data group have no attribute class of Representation. If attributes in the six classes already existed in NHDD and Chinese EHR Standard, we adopted them directly. If there were no corresponding ones, we created them according to Rules for Data Element Standardization of Health Information of China [23]. We developed 24 basic attributes for specifying metadata in openpcr (Table 1). Based on archetype models and the basic metadata attributes, we created the archetype records of openpcr. Table 1: Metadata attributes for openpcr Attribute categories Identification Attribute names MetadataIdentifier InternalName ChineseName EnglishName SynonymousNames Attribute categories Relation Attribute names Mapping Hierarchy Relevance ConditionOfUse MetadataType Usage guides Obligation Definition Definition Source Occurrence Representation (No need for Container metadata) ValueDomainName ValueDomainIdentifier DataType Administration Example RegistrationAuthority RegistrationStatus
10 Attribute categories Attribute names DataFormat Attribute categories Attribute names PermittedValue UnitOfMeasure SubmissionContact A.4 Step 4: Define Implementation Syntax The archetype models and records are semantic part of openpcr. We also developed the implementation syntax by XML, which is a simple and flexible text format used to publish and exchange a wide variety of electronic data. As a vendor neutral and platform independent markup language [24], XML is now widely used in the field of medicine. In the healthcare environment, HL7 Clinical Document Architecture (CDA) is a document markup standard for the purpose of exchange of clinical documents in XML. OpenEHR also provides XML schema to represent Archetype Object Model (AOM). In the CR environment, CDISC has developed Operational Data Model (ODM) based on XML schema to exchange and archive clinical trials data. CDISC has also released Study Design Model in XML (SDM-XML) standard which allows organizations to provide rigorous, machine-readable, interchangeable descriptions of the designs of their clinical studies. It is an extension to core ODM [25]. OpenPCR in XML will benefit for data exchange among other EHR standards or CR data standards. OpenPCR information model is composed of documents, sections, data groups, and data elements. Accordingly, information model in XML includes <document>, <section>, <data group>, and <data element>. <data group> can be nested by lower data groups using the same node tag-<data group>. We used UML to represent openpcr archetypes and to develop XML schema. Fragments
11 of the XML instances representing clinical document archetype were given to express the syntactical part of a piece of archetype records.
12 Table 2: Core functional requirements of registration and deduced metadata items in openpcr Requirement framework Extract Deduced metadata items Registration Categories Requirement description Agent 1 registration should include sponsors and collaborators information. (Ottawa 1 primary sponsor 2 secondary sponsor(s) Statement, TRDS, ClinicalTrials.gov, 3 contact for public queries ISRCTN, ChiCTR) 4 contact for scientific queries 5 source(s) of monetary or material Business 2 registration should include 6 primary registry process identification information assigned to the trial single international source. (Ottawa 7 primary trial identifying number 8 secondary identifying numbers Statement, TRDS, ClinicalTrials.gov, 9 date of registration in primary registry ISRCTN, ChiCTR) 10 date of first enrollment 3 registration should include key dates related to the process of the trial. (Ottawa Statement, TRDS, ClinicalTrials.gov, ISRCTN, ChiCTR) Record content 4 registration should include minimum protocol items to enable critical appraisal of trial methodology and statistical analyses. (Ottawa Statement, TRDS, ClinicalTrials.gov, ISRCTN, ChiCTR) 11 public title 12 scientific title 13 health condition(s) 14 intervention(s) 15 key inclusion and exclusion criteria 16 study type 17 target sample size 18 primary outcome(s) 19 key secondary outcomes 20 countries of recruitment 21 brief summary (or lay summary) Mandates 5 registration should include the consent forms approved by the IRB/IEC. (Ottawa Statement, ClinicalTrials.gov, ISRCTN) 22 board approval (or ethical approval)
13 Table 3: Core functional requirements of trial design and deduced metadata items in openpcr Requirement framework Extract Deduced metadata items Trial design Categories Requirement description Study identification 1 trial design should include study identification. (SDTMIG) 1 study identifier 2 site identifier Study 2 trial design should include primary 3 study type methods and secondary endpoints. (ICH GCP 6.4.1) 3 trial design should include study type. (ICH GCP 6.4.2) 4 method of allocation 5 blinding 6 intervention 7 dosage 4 trial design should include the measures taken to minimize/avoid bias. (ICH GCP 6.4.3, 6.4.8) 5 trial design should include trial treatment(s). (ICH GCP 6.4.4) 6 trial design should include the investigational product(s) information. (ICH GCP 6.4.4, 6.4.7) enrollment 7 trial design should include inclusion criteria. 8 trial design should include exclusion criteria. 9 trial design should include planned path of treatment. 10 trial design should include planned period of the trial and subjects. (ICH GCP 6.4.5) 8 inclusion short name 9 inclusion criterion 10 exclusion short name 11 exclusion criterion 12 arm code 13 arm description 14 order of element within arm 15 element code 16 element description 17 rules for start of element 18 epoch Visits 11 Trial design should include planned visits. 19 visit number 20 visit start rule Outcomes 12 Trial design should include the primary endpoints and the secondary endpoints. 21 primary endpoints 22 secondary endpoints
14 Table 4: Core functional requirements of CRF and deduced metadata items in openpcr Requirement framework Extract Deduced metadata items CRF Categories Requirement description Subject 1 CRF should include subject 1 Subject identifier identification identifier. (SDTMIG) Visit: screen 2 CRF should include subject s meet with inclusion and exclusion criteria. 2 Met all eligibility criteria 3 Criterion not met 3 CRF should include subject 4 Date of birth Visit: baseline demographics and additional 5 Year of birth Visit: treatment information of demographics data. 4 CRF should include subject medical history. 5 CRF should include substance the subject used. 6 Sex 7 subject characteristic question 8 subject characteristic result 9 reported medical conditions 10 type of substance used 6 CRF should include exposure 11 substance use occurrence information to study treatment. 12 start date of treatment Visit: follow up 7 CRF should include physical 13 name of the body system examined examination. 14 assessment of examined body system 8 CRF should include prior and 15 abnormal findings of physical concomitant medications. 9 CRF should include vital signs. 10 CRF should include laboratory tests. 11 CRF should include ECG test. 12 CRF should include adverse events. examination 16 medical or therapy name 17 start date of the medical or therapy 18 end date of the medical or therapy 19 vital sign name 20 vital sign result 13 CRF should include subject 21 laboratory test status disposition. 22 date of sample collection 23 laboratory test name 24 laboratory test result 25 ECG performed or not 26 date of ECG 27 name of ECG measurement 28 result of ECG measurement 29 adverse event name 30 start date of adverse event 31 end date of adverse event 32 severity of adverse event 33 serious adverse event 34 relationship of adverse event to study 35 action taken to adverse event with study 36 adverse event outcome
15 37 subject status
16 Table 5: Metadata attributes of Date of collection in laboratory test results Identification Metadata identifier Internal identifier Name Synonyms Definition Definition Source Representation Value domain name Value domain identifier Data type Data format Permitted value Units Relation Mapping hierarchy Relevance Usage guides Condition of use Obligation Occurrence openpcr-clinical.laboratory.date.v1 LBDAT Date of collection Collection date Date for sample collection. CDASHV1.0 ISO 8601 Data elements and interchange formats Information interchange Representation of dates and times ISO8601:2000 Date yyyy-mm-dd Chinese EHR Standard S HR CDASH SDTM Clinical document Laboratory test results Date of collection Mandatory No Example Administration (omitted) For submission and statistics For interoperability and future EHR/CR system of China LBDAT LBDTC versioned 3-dimensional space for easy understanding and date finding
17 <?xml version="1.0"?> <document name= clinical document > <section> <header> </header> <body> <datagroup> <physicalexamination> <datagroup> <skin> <bodysystemexamined> skin </bodysystemexamined> <examinationresult>abnormal</examinationresult> <abnormalfindings>pitting edema</abnormalfindings> </skin> </datagroup> </physicalexamination> </datagroup> </body> </section> </document> Figure 2: An example structure and XML instance of data group: skin
18 References 1. Karen Coyle, Thomas Baker. Guidelines for Dublin Core Application Profiles. c [updated May 18, 2009; cited Sept. 20, 2009]. Available from 2. Gary D. Friedman. Primer of epidemiology (3 rd edition). McGraw-Hill Book Company. 1987: Jin Pihuan, Su Binghua. Clinical Trial Design and Statistics. Shanghai Scientific & Technological Literature Publishing House. 1997: International Clinical Trials Registry Platform (ICTRP). Why is Trial Registration Important? c2013. [cited Aug. 12, 2013]. Available from 5. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6(R1). International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. [cited Sept. 20, 2009]. Available from 1/Step4/E6_R1 Guideline.pdf 6. Kush R. Can A Clinical Trial Protocol be Standardized? c2011. [cited May 5, 2011]. Available from k_ed.pdf 7. Drug Clinical Trial and the Quality Control Standard of China. [cited Nov. 20, 2012]. Available from
19 8. Ottawa Statement on Trial Registration. c [April 12, 2013]. Available from 9. International Clinical Trials Registry Platform (ICTRP). WHO Trial Registration Data Set (Version 1.2.1) c2011. [cited Aug. 5, 2011]. Available from A service of the U.S. National Institutes of Health. c2011. [cited Aug. 5, 2011]. Available from Chinese clinical trial registry. c2011. [cited Aug. 5, 2012]. Available from International Standard Randomised Controlled Trial Number Register. c2011. [cited Aug 5, 2012]. Available from isrctn_dataset 13. ClinicalTrials.gov Protocol Data Element Definitions (DRAFT). [cited April 12, 2013]. Available from ISRCTN Required Data Items and WHO ICTRP Fields. [cited April 12, 2013]. Available from Liu X,Li Y,Wu T, Liu G, Li J. A Survey of the Status of Funding of Registered Chinese Clinical Trials Survey of registration of funded clinical trial in China. Chinese Journal of Evidence-Based Medicine. 2008;8(5): CDISC Submission Data Standards Team. Study Data Tabulation Model. Texas: CDISC, Inc CDISC Submission Data Standards Team. SDTM Implementation Guide: Human Clinical Trials (SDTMIG). Texas: CDISC, Inc. 2008
20 18. CDASH_STD-1.0. Clinical Data Acquisition Standards Harmonization (CDASH). Texas: CDISC, Inc Statistics Information Center of China s ministry of health. China national health data dictionary and metadatamanagement system (DRAFT). [cited April 20, 2013]. Available from Electronic Health Record (EHR) Architecture and Data Standard (trial version). c2011. [cited April 20, 2013]. Available from W. Davenport Robertson, Ellen M. Leadem, Jed Dube. Design and Implementation of the National Institute of Environmental: Health Sciences Dublin Core Metadata Schema. Proc. Int l. Conf. on Dublin Core and Metadata Applications 2001: ISO/IEC Information technology Metadata registries (MDR) Part 3:Registry metamodel and basic attributes. [S] Geneva: ISO copyright office, WS/T S Rules for data element standardization of health information of China. [S] China, China's Ministry of Health, Extensible Markup Language (XML) 1.0 (Fifth Edition). c2008. [cited April 12, 2013]. Available from CDISC Study Design Model in XML (SDM-XML). c [cited April 12, 2013]. Available from c/cdisc_sdm_xml_1.0.pdf
The REUSE project: EHR as single datasource for biomedical research
The REUSE project: EHR as single datasource for biomedical research Naji El Fadly 1,3, Noël Lucas 2, Pierre-Yves Lastic 4, François Macary 5, Philippe Verplancke 6, Christel Daniel 1,2 1 INSERM UMRS 872,
More informationBRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA
BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC),
More informationTraining/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program
Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program Domain Clinical Data Sciences Private Limited 8-2-611/1/2, Road No 11, Banjara Hills, Hyderabad Andhra Pradesh
More informationEinführung in die CDISC Standards CDISC Standards around the World. Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14.
Einführung in die CDISC Standards CDISC Standards around the World Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14. März 2015 1 Outline Overview of CDISC Therapeutic Area Standards SHARE Metadata
More informationA Standard Computable Clinical Trial Protocol: The Role of the BRIDG Model
CLINICAL RESEARCH STANDARDS 383 Cara Willoughby, MS Eli Lilly and Company, Indianapolis, Indiana Doug Fridsma, MD, PhD University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Lisa Chatterjee,
More informationElectronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management
Written Notice of Participation by the Clinical Data Interchange Standards Consortium (CDISC) and Written Statement for Discussion Topics to be Addressed In the FDA Public Hearing: Electronic Submission
More informationIntroduction to the CDISC Standards
Introduction to the CDISC Standards Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC) encompasses a suite of standards across
More informationUse of standards: can we really be analysis ready?
Standards in analysis & reporting Use of standards: can we really be analysis ready? Analysis ready? Why? Reducing time to market/approval Reducing time to delivery Reducing re work Designing subsequent
More informationOverview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)
Overview of CDISC Implementation at PMDA Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 Outline Introduction Update of PMDA activity CDISC implementation
More informationUdo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL
Innovative Medicines Technological Platform Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL Facts about PAREXEL Full service CRO (Clinical Research Organisation) Involved in more than
More informationPharmaSUG2010 - Paper HS01. CDASH Standards for Medical Device Trials: CRF Analysis. Parag Shiralkar eclinical Solutions, a Division of Eliassen Group
PharmaSUG2010 - Paper HS01 CDASH Standards for Medical Device Trials: CRF Analysis Parag Shiralkar eclinical Solutions, a Division of Eliassen Group Jennie Tedrow Boston Scientific Kit Howard Kestrel Consultants
More informationHistory and Principles of Good Clinical Practice
History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices
More informationCopyright 2012, SAS Institute Inc. All rights reserved. VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS
VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS WENJUN BAO AND JASON CHEN JMP, SAS INC. PHUSE, SHANGHAI, NOV 28, 2014 OUTLINES: CDISC Standard SDTM ADaM Interactive Standardized TLFs Tables
More informationNote: See 7.7 Representations and Warranties, Limitations of Liability, and Disclaimer.
Clinical Data Acquisition Standards Harmonization (CDASH) Prepared by: CDISC and Domain Teams CDASH_STD-1.0 01/OCT/2008 CDASH V1.0 STANDARD Revision History Document Number Release Date Updates CDASH_STD-1.0
More informationCDISC and Clinical Research Standards in the LHS
CDISC and Clinical Research Standards in the LHS Learning Health System in Europe 24 September 2015, Brussels Rebecca D. Kush, PhD, President and CEO, CDISC CDISC 2015 1 CDISC Healthcare Link Goal: Optimize
More informationProgramme Guide PGDCDM
Post Graduate Diploma in Clinical Data Management and Biostatistics with SAS Programme Guide PGDCDM School of Health Sciences Indira Gandhi National Open University WHY THIS PROGRAMME? The Post Graduate
More informationSpecifics of the clinical trials data life cycle (momentum for providing access to patient-level data)
Specifics of the clinical trials data life cycle (momentum for providing access to patient-level data) 3rd EUDAT Conference 25 September 2014 Amsterdam, Netherlands Prof. Dr. C. Ohmann ECRIN-ERIC Major
More informationCDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co
CDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co CDISC Ausblick: Weitere Entwicklung und Konvergenz der CDISC-Standards SDTM, ODM & Co. Jozef Aerts - XML4Pharma Disclaimer Views
More informationChallenges and Opportunities in Clinical Trial Data Processing
Challenges and Opportunities in Clinical Trial Data Processing Vadim Tantsyura, Olive Yuan, Ph.D. Sergiy Sirichenko (Regeneron Pharmaceuticals, Inc., Tarrytown, NY) PG 225 Introduction The review and approval
More informationData Standards and the National Cardiovascular Research Infrastructure (NCRI)
Data Standards and the National Cardiovascular Research Infrastructure (NCRI) A partnership with Duke Clinical Research Institute (DCRI) and the American College of Cardiology Foundation (ACCF) November
More informationUSE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE
USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE Kalyani Chilukuri, Clinovo, Sunnyvale CA WUSS 2011 Annual Conference October 2011 TABLE OF CONTENTS 1. ABSTRACT... 3 2. INTRODUCTION...
More informationData modelling methods in clinical trials: Experiences from the CTMND project (ctmnd.org)
Data modelling methods in clinical trials: Experiences from the CTMND project (ctmnd.org) Athanasios Anastasiou, Emmanuel Ifeachor, John Zajicek & the CTMND Consortium University of Plymouth Peninsula
More informationAccelerating Clinical Trials Through Shared Access to Patient Records
INTERSYSTEMS WHITE PAPER Accelerating Clinical Trials Through Shared Access to Patient Records Improved Access to Clinical Data Across Hospitals and Systems Helps Pharmaceutical Companies Reduce Delays
More informationUnderstanding CDISC Basics
Trends in Bio/Pharmaceutical Industry Understanding CDISC Basics Jane Ma Abstract Data standards can make data and its associated program more portable. The CDISC (Clinical Data Interchange Standards Consortium)
More informationUse of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009
Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009 Table of Contents 1.0 Preface...4 2.0 Introduction and Scope...6 3.0 Use Case
More informationEHR Standards Landscape
EHR Standards Landscape Dr Dipak Kalra Centre for Health Informatics and Multiprofessional Education (CHIME) University College London d.kalra@chime.ucl.ac.uk A trans-national ehealth Infostructure Wellness
More informationABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07
Paper PH-07 Developing a Complete Picture of Patient Safety in Clinical Trials Richard C. Zink, JMP Life Sciences, SAS Institute, Cary, NC, United States Russell D. Wolfinger, JMP Life Sciences, SAS Institute,
More information4. Executive Summary of Part 1 FDA Overview of Current Environment
Public Meeting Regulatory New Drug Review: Solutions for Study Data Exchange Standards 1. Background Meeting Summary Food and Drug Administration White Oak, MD November 5, 2012 10am 4pm On November 5,
More informationImplementation of SDTM in a pharma company with complete outsourcing strategy. Annamaria Muraro Helsinn Healthcare Lugano, Switzerland
Italian-Speaking CDISC User Group 2008 Implementation of SDTM in a pharma company with complete outsourcing strategy Annamaria Muraro Helsinn Healthcare Lugano, Switzerland Background Full outsourcing
More informationSubject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
More informationSingapore Clinical Trials Register. Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY
Singapore Clinical Trials Register Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY Clinical Trial Register Global Trend EMA: EU Clinical Trials
More informationSAS CLINICAL TRAINING
SAS CLINICAL TRAINING Presented By 3S Business Corporation Inc www.3sbc.com Call us at : 281-823-9222 Mail us at : info@3sbc.com Table of Contents S.No TOPICS 1 Introduction to Clinical Trials 2 Introduction
More informationCDISC Strategy Document Version 9 (Final BOD Approved Version) 4 December 2006
CDISC Strategy Document Version 9 (Final BOD Approved Version) 4 December 2006 Introduction The Clinical Data Interchange Standards Consortium (CDISC) has established standards to support the acquisition,
More informationThe CDISC Healthcare Link Initiative
Value Proposition The CDISC Healthcare Link Initiative Spontaneous Triggered Adverse Drug Event Reporting (ASTER) In 2008, a pilot project was launched between CDISC, CRIX, Pfizer, Brigham and Women s
More informationPilot. Pathway into the Future for. Delivery. April 2010 Bron W. Kisler, CDISC Senior Director bkisler@cdisc.org
SHARE S&V Document and the Pilot Pathway into the Future for Standards Development and Delivery April 2010 Bron W. Kisler, CDISC Senior Director bkisler@cdisc.org 1 CDISC Mission To develop and support
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationABSTRACT On October 1st, 2008, CDASH released the first 16 common CRF streams (or domains) for use by the Pharmaceutical Industry.
Paper RS03-2008 A Practical Introduction to Clinical Data Acquisition Standards Harmonization (CDASH) Jennifer Price, Phoenix Data Systems, Inc, King of Prussia, PA ABSTRACT On October 1st, 2008, CDASH
More informationStructured Data Capture (SDC) Trial Implementation
Integrating the Healthcare Enterprise 5 IHE Quality, Research, and Public Health Technical Framework Supplement 10 Structured Data Capture (SDC) 15 Trial Implementation 20 Date: October 27, 2015 Author:
More informationStreamlining the Flow of Clinical Trial Data: EHR to EDC to Sponsor
Streamlining the Flow of Clinical Trial : EHR to EDC to Sponsor Landen Bain Liaison to Healthcare CDISC Interchange Standards Consortium) Jane Griffin, RPh Director, Pharmaceutical Research Cerner Corporation
More informationCLINICAL RESEARCH PROTOCOL CHECKLIST
CLINICAL RESEARCH PROTOCOL CHECKLIST [taken from ICH GCP : Guidance for Industry, Good Clinical Practice: Consolidated Guidance, Revision 1 (R1) June 1996] ICH GCP, Section 6. CLINICAL TRIAL PROTOCOL AND
More informationStatistical Operations: The Other Half of Good Statistical Practice
Integrating science, technology and experienced implementation Statistical Operations: The Other Half of Good Statistical Practice Alan Hopkins, Ph.D. Theravance, Inc. Presented at FDA/Industry Statistics
More informationLessons on the Metadata Approach. Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014
1 Lessons on the Metadata Approach Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014 2 Experience Human beings, who are almost unique in having the ability to learn from the experience of
More informationOntology-based Archetype Interoperability and Management
Ontology-based Archetype Interoperability and Management Catalina Martínez-Costa, Marcos Menárguez-Tortosa, J. T. Fernández-Breis Departamento de Informática y Sistemas, Facultad de Informática Universidad
More informationThe ADaM Solutions to Non-endpoints Analyses
The ADaM Solutions to Non-endpoints Analyses ABSTRACT Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA There always exist some analyses for non endpoints in the study. These
More informationBusiness & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies
Business & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies Jessica Minkue Mi Edou / 18th September 2014 From SDTM to ADaM: Mapping Methodologies CDISC and ADaM Introduc0on
More informationEHR4CR ENABLING PROACTIVE RESEARCH
EHR4CR ENABLING PROACTIVE RESEARCH Neelam Patel Neelam Consulting Electronic Health Records for Clinical Research 76 Why change how I currently operate? To more visible to the clinical trial community
More informationEnd-to-End E-Clinical Coverage with Oracle Health Sciences InForm GTM
End-to-End E-Clinical Coverage with InForm GTM A Complete Solution for Global Clinical Trials The broad market acceptance of electronic data capture (EDC) technology, coupled with an industry moving toward
More informationTelling the Data Story: Use of Informatics, Harmonized Semantics and Metadata in the National Children s Study
Telling the Data Story: Use of Informatics, Harmonized Semantics and Metadata in the National Children s Study John Lumpkin, MS, MBA, PMP Steven Hirschfeld, MD, PhD NIH-NICHD-National Children s Study
More informationBridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission
, October 24-26, 2012, San Francisco, USA Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission Abstract In this article, the relationship between the Statistical Analysis Plan
More informationBusiness & Decision Life Sciences What s new in ADaM
Business & Decision Life Sciences What s new in ADaM Gavin Winpenny 23 rd June 2015 Agenda What s happening CDISC and Regulatory Submission Landscape ADaM Implementation Guide ADaM Data Structures for
More informationSemantic interoperability of dual-model EHR clinical standards
Semantic interoperability of dual-model EHR clinical standards Catalina Martínez-Costa Departamento de Informática y Sistemas, Facultad de Informática Universidad de Murcia, CP 30100, Murcia cmartinezcosta@um.es
More informationCurrent Status and Future Perspectives for Systemization of Clinical Study related the issues of CDISC in USA and other
Current Status and Future Perspectives for Systemization of Clinical Study related the issues of CDISC in USA and other ABSTRACT The term "the CDISC standard" has been used incorrectly for a few years.
More informationThe Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data. Ravi Shankar
The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data Ravi Shankar Open access to clinical trials data advances open science Broad open access to entire clinical
More informationREGULATIONS FOR THE POSTGRADUATE DIPLOMA IN CLINICAL RESEARCH METHODOLOGY (PDipClinResMethodology)
452 REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN CLINICAL RESEARCH METHODOLOGY (PDipClinResMethodology) (See also General Regulations) M.57 Admission requirements To be eligible for admission to the courses
More informationPhUSE 2010. Paper CD13
Paper CD13 Clinical Data Interchange Standards Consortium (CDISC) integration into the Oracle Clinical/Remote Data Capture (OC/RDC) clinical data management system Peter Van Reusel, Business & Decision
More informationSTUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
More informationAnnette Pollex-Krüger, Johannes Drepper, Sebastian C. Semler. Telematikplattform für Medizinische Forschungsnetze (TMF) e.v.
TMF A Common Platform for Medical Research Networks in Germany Improving the Organisation and Infrastructure of Medical Research in Cooperative Structures ELN Workshop on Information Technology II Heidelberg,
More informationSTUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
More informationECRIN (European Clinical Research Infrastructures Network)
ECRIN (European Clinical Research Infrastructures Network) Wolfgang Kuchinke University of Duesseldorf (HHU) and ECRIN EUDAT 1st User Forum 7 March 2012 8 March 2012, Barcelona 1 What is ECRIN? European
More informationOptimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools
Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools Laura McKain, M.D., Medical Director, Pharmacovigilance; Tammy Jackson, Director, Preclarus Development, Clinical Innovation;
More informationINTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
More informationThe Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research
The Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research Eileen C King, PhD Research Associate Professor, Biostatistics Acting Director, Data Management
More informationClinical Data Interchange Standards Consortium Electronic Source Data Interchange (esdi) Group
Clinical Data Interchange Standards Consortium Electronic Source Data Interchange (esdi) Group Leveraging the CDISC Standards to Facilitate the use of Electronic Source Data within Clinical Trials Version
More information11. Extension Potential Financial Benefits
11. Extension Potential Financial Benefits Estimating the financial value of using electronic health records (EHR) for clinical research is fraught with difficulties for a number of reasons, some of which
More informationManaging and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners
Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical
More informationImplementation and Operation of CDISC ODM-based EDC by UMIN
Implementation and Operation of CDISC ODM-based EDC by UMIN Takahiro Kiuchi, M.D., Ph.D. UMIN Center, The University of Tokyo Hospital, Tokyo, Japan 1 Content 1. CDISC standards and academic research 2.
More informationPONTE Presentation CETIC. EU Open Day, Cambridge, 31/01/2012. Philippe Massonet
PONTE Presentation CETIC Philippe Massonet EU Open Day, Cambridge, 31/01/2012 PONTE Description Efficient Patient Recruitment for Innovative Clinical Trials of Existing Drugs to other Indications Start
More informationSCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS
UDC 615:519.076 Dobrova V. Ye., Zupanets K. O., Ratushna K. L. National University of Pharmacy SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL
More informationData Conversion to SDTM: What Sponsors Can Do to Facilitate the Process
Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process Fred Wood VP, Data Standards Consulting Octagon Research Solutions CDISC U.S. Interchange Baltimore, MD November 2009 1 Outline Background
More informationMetadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide
Metadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide Prepared by the CDISC SDS Metadata Team Notes to Readers This is Version 0.9 of the Metadata Submissions
More informationSheffield Kidney Institute. Planning a Clinical Trial
Planning a Clinical Trial Clinical Trials Testing a new drug Ethical Issues Liability and Indemnity Trial Design Trial Protocol Statistical analysis Clinical Trials Phase I: Phase II: Phase III: Phase
More informationAccenture Accelerated R&D Services: CDISC Conversion Service Overview
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Accenture Accelerated R&D Services: CDISC Conversion Service Overview Using standards to drive speed to market and meet regulatory
More informationAnalysis Data Model (ADaM)
Analysis Data Model (ADaM) Prepared by the CDISC Analysis Data Model Team Notes to Readers This is Version 2.1 of the Analysis Data Model (ADaM) Document. It includes modifications so that it corresponds
More informationFHIM Model Content Overview
FHIM Model Content Overview Federal Health Information Model (FHIM) and Associated Terminology Models Goal Produce a logical, health information model that supports semantic interoperability and that is
More informationExecutive Summary for deliverable D7.1: Establish specification for data acquisition and standards used including a concept for local interfaces
Electronic Health Records for Clinical Research Executive Summary for deliverable D7.1: Establish specification for data acquisition and standards used including a concept for local interfaces Project
More informationThe CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions
Paper RS10 The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions ABSTRACT The CDISC (Clinical Data Interchange Standards
More informationBringing Order to Your Clinical Data Making it Manageable and Meaningful
CLINICAL DATA MANAGEMENT Bringing Order to Your Clinical Data Making it Manageable and Meaningful eclinicalsol.com DATA IS SIMPLY BEAUTIFUL DATA STACKS IN STANDARD FORMATION This imaginative visual suggests
More informationAdvanced Aspects of Hospital Information Systems
Advanced Aspects of Hospital Information Systems EHR- and related Standards DI Harald Köstinger (harald.koestinger@inso.tuwien.ac.at) INSO - Industrial Software Institut für Rechnergestützte Automation
More informationXClinical offers an integrated range of software products for CROs, pharmaceutical, medical device and biopharmaceutical companies.
XCLINICAL Software & Services - Fast - Flexible - Focused XClinical offers an integrated range of software products for CROs, pharmaceutical, medical device and biopharmaceutical companies. Our products
More informationAutomate Data Integration Processes for Pharmaceutical Data Warehouse
Paper AD01 Automate Data Integration Processes for Pharmaceutical Data Warehouse Sandy Lei, Johnson & Johnson Pharmaceutical Research and Development, L.L.C, Titusville, NJ Kwang-Shi Shu, Johnson & Johnson
More informationRelationship of HL7 EHR System Draft Standard to X12N
Relationship of HL7 EHR System Draft Standard to X12N EHR Technical Committee Co-Chairs: Gary Dickinson Linda Fischetti Sam Heard Excerpt of EHR-S DSTU Class Overview of Discussion Background Where We
More informationADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA
ABSTRACT: ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA Over the past few years, the United States Food
More informationWHITE PAPER. CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. SUCCESSFUL TRIALS THROUGH PROVEN SOLUTIONS
WHITE PAPER CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. An innovative approach to deliver statistical analysis and data in a CDISC ADaM complient manner
More informationPharmaSUG2010 HW06. Insights into ADaM. Matthew Becker, PharmaNet, Cary, NC, United States
PharmaSUG2010 HW06 Insights into ADaM Matthew Becker, PharmaNet, Cary, NC, United States ABSTRACT ADaM (Analysis Dataset Model) is meant to describe the data attributes such as structure, content, and
More informationREGULATIONS FOR THE POSTGRADUATE DIPLOMA IN CLINICAL RESEARCH METHODOLOGY (PDipClinResMethodology)
463 REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN CLINICAL RESEARCH METHODOLOGY (PDipClinResMethodology) (See also General Regulations) M.57 Admission requirements To be eligible for admission to the courses
More informationTurkey s National Health Information System (NHIS)
Turkey s National Health Information System (NHIS) İlker KÖSE 1, Nihat AKPINAR 1, Murat GÜREL 1, Yakup ARSLAN 1, Hakan ÖZER 1, Nihat YURT 1, Yıldıray KABAK 2, Asuman DOGAC 3 1 Dept. of Information Processing,
More informationCDISC Data Standards Can Facilitate Composition of Adverse Event Narratives
CDISC Data Standards Can Facilitate Composition of Adverse Event Narratives Anisa Scott, Ph.D. and Richard C. Zink, Ph.D. JMP Life Sciences SAS Institute, Inc. anisa.scott@jmp.com Copyright 2010 SAS Institute
More informationData models standards to define, exchange and archive data
Data models standards to define, exchange and archive data MedInfo 2013, Copenhagen Dr. Bernhard Breil HL7 CDA CDA = Clinical Document Architecture Defined by HL7 Available at hmp://www.hl7.org/implement/standards/product_brief.cfm?product_id=7
More informationThe Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
More informationRationale and vision for E2E data standards: the need for a MDR
E2E data standards, the need for a new generation of metadata repositories Isabelle de Zegher, PAREXEL Informatics, Belgium Alan Cantrell, PAREXEL, United Kingdom Julie James, PAREXEL Informatics, United
More informationHL7 and SOA Based Distributed Electronic Patient Record Architecture Using Open EMR
HL7 and SOA Based Distributed Electronic Patient Record Architecture Using Open EMR Priti Kalode 1, Dr Onkar S Kemkar 2, Dr P R Gundalwar 3 Research Student, Dept of Comp Sci &Elec, RTM Nagpur University
More informationTherapeutic Area Standards (TAS) Initiative Project Plan
Therapeutic Area Standards (TAS) Initiative Project Plan Version: 2.0 Document Date: June, 2014 REVISION HISTORY Version Number Revision Date Description of Change 1.0 September, 2013 Initial Document
More informationWhat is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
More informationReport of the secretariat. CEN/TC 251 secretariat ACTION REQUIRED: For your information
Secretariat: doc.nr. Vlinderweg 6 P.O. box 5059 CEN/TC 251 N11-014 2623 AX Delft 2600 GB Delft date The Netherlands The Netherlands 2011-02-21 total pages 8 Secretary: Ms Shirin Golyardi Committee CEN/TC
More informationOverview of the CDISC Operational Data Model for Clinical Data Acquisition and Archive (based on CDISC DTD 1.1 Final)
Overview of the CDISC Operational Data Model for Clinical Data Acquisition and Archive (based on CDISC DTD 1.1 Final) Copyright 2002 CDISC April 26, 2002 History and Background Historically there has been
More informationTechniques for ensuring interoperability in an Electronic health Record
Techniques for ensuring interoperability in an Electronic health Record Author: Ovidiu Petru STAN 1. INTRODUCTION Electronic Health Records (EHRs) have a tremendous potential to improve health outcomes
More informationPharmaSUG 2015 - Paper DS02
PharmaSUG 05 - Paper DS0 SDTM TE, T, and SE Domains: Demystifying the Development of SE Kristin Kelly, ccenture ccelerated R&D Services, erwyn, P Fred Wood, ccenture ccelerated R&D Services, erwyn, P Jerry
More informationComment Form: WHO Statement on Public Disclosure of Clinical Trial Results. Suggested Amendment
Form: WHO Statement on Public Disclosure of Clinical Trial Results Page 1 of 6 as individual or on behalf of agency or institution?: Institution er's Name in Full, Title, Institution, City, Country, Tel.,
More informationUsing the SAS XML Mapper and ODS PDF to create a PDF representation of the define.xml (that can be printed)
Using the SAS XML Mapper and ODS PDF to create a PDF representation of the define.xml (that can be printed) Lex Jansen TAKE Solutions CDISC Atlantic User Group Meeting 2008-02-21 Regulatory Landscape (FDA)
More information